HEATHER DAVIS: Open Payments
NPI 1023190477 · NASHVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,856 in 148 payments from 21 companies in 2025. Trend: 2023 $1,044 · 2024 $1,609 · 2025 $2,856
Food & beverage: $2,856
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $433 |
| ABBVIE INC. | 21 | $388 |
| Novo Nordisk Inc | 14 | $250 |
| PFIZER INC. | 17 | $250 |
| Corcept Therapeutics | 10 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $190 |
| Corium, LLC | 8 | $168 |
| Amgen Inc. | 11 | $139 |
| Otsuka America Pharmaceutical, Inc. | 6 | $110 |
| AstraZeneca Pharmaceuticals LP | 6 | $107 |
Products named: Auvelity, Korlym, CAPLYTA, Azstarys, UBRELVY, NURTEC ODT, REXULTI, VRAYLAR.
Industry payments across NC — which companies pay providers there.
